Horizon Therapeutics Public Ltd Co Net Cash Provided by (Used in) Financing Activities in USD from 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Horizon Therapeutics Public Ltd Co quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2023.
  • Horizon Therapeutics Public Ltd Co Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was -$88.1M, a 19.9% increase year-over-year.
  • Horizon Therapeutics Public Ltd Co annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$348M, a 124% decline from 2021.
  • Horizon Therapeutics Public Ltd Co annual Net Cash Provided by (Used in) Financing Activities for 2021 was $1.47B, a 62.5% increase from 2020.
  • Horizon Therapeutics Public Ltd Co annual Net Cash Provided by (Used in) Financing Activities for 2020 was $905M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Horizon Therapeutics Public Ltd Co Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$88.1M +$21.9M +19.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-03
Q1 2022 -$110M -$1.58B -107% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q1 2021 $1.47B +$1.51B Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 -$39.6M -$60.2M -292% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $20.6M +$25.3M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 -$4.68M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2014 $24.2M Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-09
Q1 2012 $83.3M +$79.7M +2165% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q1 2011 $3.68M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10

Horizon Therapeutics Public Ltd Co Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$348M -$1.82B -124% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-01
2021 $1.47B +$566M +62.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 $905M +$1.2B Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$290M -$274M -1650% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$16.6M -$70.9M -131% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $54.3M -$603M -91.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $657M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2014 $338M +$272M +407% Jan 1, 2014 Dec 31, 2014 10-K/A 2015-03-02
2013 $66.7M -$97.6M -59.4% Jan 1, 2013 Dec 31, 2013 10-K/A 2015-03-02
2012 $164M +$109M +198% Jan 1, 2012 Dec 31, 2012 10-K/A 2015-03-02
2011 $55.2M +$25.4M +85.3% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-13
2010 $29.8M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.